Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimycobacterial therapy.

R E Van Scoy1, C J Wilkowske

  • 1Division of Infectious Diseases and Internal Medicine, Mayo Clinic Rochester, Minnesota, USA.

Mayo Clinic Proceedings
|August 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ABO Blood Groups of Siblings of Duodenal Ulcer Patients.

British medical journal·2010
Same author

ABO Blood Groups of Siblings of Gastric Ulcer and Gastric Carcinoma Patients.

British medical journal·2010
Same author

Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996
Same author

Disseminated cutaneous Mycobacterium avium-intracellulare resembling sarcoidosis.

Journal of the American Academy of Dermatology·1995
Same author

Implementing an EMR: paper's last hurrah.

Proceedings. Symposium on Computer Applications in Medical Care·1995
Same author

Fever of unknown origin.

Singapore medical journal·1993
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Tuberculosis (TB) and Mycobacterium avium complex infections are increasing globally, especially in immunocompromised individuals. This review offers primary care providers guidance on prevention and treatment strategies using limited resources.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Tuberculosis (TB) remains a leading global cause of morbidity and mortality.
  • The rise in acquired immunodeficiency syndrome (AIDS) and other immunocompromised conditions has significantly increased Mycobacterium avium-intracellulare complex (MAC) infections.
  • While diagnostic, preventive, and therapeutic interventions exist, their implementation is hampered by resource limitations and organizational challenges.

Purpose of the Study:

  • To provide primary care providers with a comprehensive review of TB prevention and treatment.
  • To address the management of specific mycobacterial infections, including MAC.
  • To offer guidance on the judicious use of antimycobacterial agents.

Main Methods:

  • Review of current literature and guidelines on tuberculosis and other mycobacterial infections.

Related Experiment Videos

  • Inclusion of the six core recommendations from the Centers for Disease Control and Prevention (CDC) for TB management.
  • Summarization of information on key antimycobacterial drugs: isoniazid, rifampin, rifabutin, pyrazinamide, and ethambutol.

    • Main Results:

    • The review synthesizes available data on effective diagnostic, preventive, and treatment measures for TB and MAC.
    • It highlights the challenges posed by limited resources and the need for organized implementation strategies.
    • Key information on first-line antimycobacterial agents is presented for practical application.

    Conclusions:

    • Effective strategies for TB and MAC prevention and treatment are available but require careful resource allocation and organized implementation.
    • Primary care providers play a crucial role in managing these infections, necessitating accessible and practical guidance.
    • This review aims to equip healthcare providers with the knowledge to optimize patient care within resource-constrained settings.